DiaCarta, Inc. Company Contacts

DiaCarta, Inc.

http://www.diacarta.com
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational... Read More
Contacts

Country

United States

City

Pleasanton

Headquarters

Pleasanton, California

Profile

Founded

2012

Industry

Biotechnology

Size

11 - 50

Specialties

Precision Molecular Diagnostics, Translational Genomics, CLIA Lab, XNA Technology, SuperbDNA Technology, NGS, Liquid Biopsy, Cancer Mutation Detection, Colorectal Cancer Mutation Detection, In-Vitro Diagnostics, Precision Medicine, Personalized Radiation Therapy, HPV mRNA Test, Cervical Cancer Screening, Head and Neck Cancer Screening, Early Cancer Detection, CAR-T and Immuno therapy, Whole Genome Sequencing

Funding

Total Rounds

2

Last Round

Mon Feb 12 2018

Last Round Series

Series B

Last Round Raised

$ 45,000,000